NYXH

Nyxoah SA

Price Chart

No historical data available

Latest Quote

$0.91

+0.05 (+6.35%)

Current Price

Previous Close	$0.86
Open	$0.93
Day High	$0.93
Day Low	$0.89
Volume	295,915

Fetched: 2026-10-27T21:00:39

Stock Information

Note: Financial values converted from EUR to USD

Shares Outstanding	101.84M
Total Debt	$66.76M
Cash Equivalents	$108.82M
Revenue	$24.11M
Net Income	$-106.84M
Sector	Healthcare
Industry	Medical Devices
Market Cap	$92.76M
EPS (TTM)	$-2.33
Exchange	NGM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Nyxoah SA

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

📰 Latest News

No news articles available at the moment. Check back later for updates on NYXH.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$596,848	$131,888	$377,780	$147,535
Cost Of Revenue	$4,128,758	$1,734,660	$1,850,900	$1,285,347
Total Revenue	$11,199,285	$5,053,091	$4,859,730	$3,446,966
Operating Revenue	$11,199,285	$5,053,091	$4,859,730	$3,446,966
Expenses
Interest Expense	$2,065,497	$990,276	$242,539	$264,893
Total Expenses	$103,902,986	$70,783,504	$55,269,924	$39,770,874
Rent Expense Supplemental	$551,023	$714,206	$354,309	$491,785
Other Income Expense	$-2,144,853	$1,987,258	$-1,033,866	$3,223,427
Net Non Operating Interest Income Expense	$-4,714,429	$669,498	$1,531,240	$-492,903
Total Other Finance Cost	$4,698,782	$1,136,694	$1,099,810	$643,791
Interest Expense Non Operating	$2,065,497	$990,276	$242,539	$264,893
Operating Expense	$99,774,228	$69,048,844	$53,419,024	$38,485,527
Other Operating Expenses	$-1,472,002	$-1,126,635	$-608,025	$-316,307
General And Administrative Expense	$51,902,314	$30,375,545	$23,074,774	$20,052,532
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-100,687,383	$-66,207,668	$-48,297,754	$-34,899,967
Net Interest Income	$-4,714,429	$669,498	$1,531,240	$-492,903
Interest Income	$2,049,849	$2,796,468	$2,873,589	$415,782
Normalized Income	$-99,078,743	$-67,698,112	$-47,297,342	$-37,317,537
Net Income From Continuing And Discontinued Operation	$-100,687,383	$-66,207,668	$-48,297,754	$-34,899,967
Total Operating Income As Reported	$-93,310,608	$-65,730,414	$-50,410,194	$-36,323,908
Net Income Common Stockholders	$-100,687,383	$-66,207,668	$-48,297,754	$-34,899,967
Net Income	$-100,687,383	$-66,207,668	$-48,297,754	$-34,899,967
Net Income Including Noncontrolling Interests	$-100,687,383	$-66,207,668	$-48,297,754	$-34,899,967
Net Income Continuous Operations	$-100,687,383	$-66,207,668	$-48,297,754	$-34,899,967
Pretax Income	$-99,559,631	$-63,073,657	$-49,912,821	$-33,593,384
Special Income Charges	$-610,260	$0	$0	-
Interest Income Non Operating	$2,049,849	$2,796,468	$2,873,589	$415,782
Operating Income	$-92,703,701	$-65,730,414	$-50,410,194	$-36,323,908
Depreciation Amortization Depletion Income Statement	$1,479,826	$1,435,118	$1,164,636	$1,021,571
Depreciation And Amortization In Income Statement	$1,479,826	$1,435,118	$1,164,636	$1,021,571
Gross Profit	$7,070,527	$3,318,431	$3,008,830	$2,161,618
Per Share
Diluted EPS	$-2.64	$-2.02	$-1.73	$-1.35
Basic EPS	$-2.64	$-2.02	$-1.73	$-1.35
Other
Tax Effect Of Unusual Items	$-536,213	$496,815	$-33,454	$805,857
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-90,337,545	$-61,032,749	$-45,998,660	$-34,392,534
Total Unusual Items	$-2,144,853	$1,987,258	$-1,033,866	$3,223,427
Total Unusual Items Excluding Goodwill	$-2,144,853	$1,987,258	$-1,033,866	$3,223,427
Reconciled Depreciation	$5,011,736	$3,037,890	$2,637,756	$2,159,383
EBITDA (Bullshit earnings)	$-92,482,398	$-59,045,491	$-47,032,526	$-31,169,107
EBIT	$-97,494,134	$-62,083,381	$-49,670,281	$-33,328,491
Diluted Average Shares	$42,591,956	$36,599,043	$31,259,799	$28,866,805
Basic Average Shares	$42,591,956	$36,599,043	$31,259,799	$28,866,805
Diluted NI Availto Com Stockholders	$-100,687,383	$-66,207,668	$-48,297,754	$-34,899,967
Tax Provision	$1,127,752	$3,134,011	$-1,615,067	$1,306,583
Gain On Sale Of Ppe	$-181,066	$0	$0	-
Other Special Charges	$-133,005	-	-	-
Write Off	$562,200	$0	$0	-
Gain On Sale Of Security	$-1,534,593	$1,987,258	$-1,033,866	$3,223,427
Research And Development	$47,864,089	$38,364,816	$29,787,639	$17,727,730
Selling General And Administration	$51,902,314	$30,375,545	$23,074,774	$20,052,532
Other Gand A	$21,428,412	$16,341,791	$11,621,773	$8,875,601
Insurance And Claims	$481,726	$571,141	$1,100,928	$1,681,010
Rent And Landing Fees	$551,023	$714,206	$354,309	$491,785
Salaries And Wages	$29,441,154	$12,748,407	$9,997,765	$9,004,136

Fetched: 2026-10-26

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$-1,094,222	$70,272,718	$57,465,073	$89,808,876
Total Assets	$132,414,219	$177,049,293	$138,769,422	$163,262,549
Total Non Current Assets	$63,996,872	$67,422,601	$62,373,981	$51,202,639
Non Current Deferred Assets	$97,239	$84,945	$62,591	$52,532
Non Current Deferred Taxes Assets	$97,239	$84,945	$62,591	$52,532
Non Current Accounts Receivable	$1,818,487	$1,682,128	$1,303,230	$193,361
Financial Assets	$101,710	$125,182	-	-
Goodwill And Other Intangible Assets	$56,005,366	$56,310,496	$52,093,440	$44,676,429
Other Intangible Assets	$56,005,366	$56,310,496	$52,093,440	$44,676,429
Current Assets	$68,417,348	$109,626,692	$76,395,441	$112,059,910
Hedging Assets Current	$4,471	$0	$383,369	$1,118
Current Deferred Assets	$741,031	$1,026,042	-	-
Prepaid Assets	$343,132	$820,387	-	-
Inventory	$5,208,450	$5,271,041	$3,705,153	$985,805
Receivables	$8,469,878	$6,884,989	$6,289,259	$3,617,973
Other Receivables	$1,004,806	$1,195,932	$1,353,526	$858,388
Taxes Receivable	$1,592,713	$1,909,020	$1,853,135	$1,124,399
Accounts Receivable	$5,872,360	$3,780,038	$3,082,598	$1,635,185
Cash Cash Equivalents And Short Term Investments	$53,650,386	$95,624,233	$64,544,541	$106,019,897
Cash And Cash Equivalents	$33,531,911	$38,209,456	$24,153,348	$19,993,294
Cash Equivalents	$24,735,666	$31,541,299	$10,235,833	$40,237
Cash Financial	$8,796,245	$6,668,157	$13,917,514	$19,953,057
Other Current Assets	-	$1,850,900	$1,473,120	$1,435,118
Debt
Net Debt	$10,124,064	-	-	-
Total Debt	$45,238,628	$25,319,102	$14,199,173	$13,281,547
Long Term Debt And Capital Lease Obligation	$18,672,181	$23,792,333	$12,841,176	$12,043,143
Long Term Debt	$17,960,210	$20,928,803	$9,358,444	$9,152,789
Current Debt And Capital Lease Obligation	$26,566,447	$1,526,769	$1,357,997	$1,238,404
Current Debt	$25,695,764	$277,188	$406,840	$434,783
Other Current Borrowings	$25,695,764	$277,188	$406,840	$434,783
Liabilities
Total Liabilities Net Minority Interest	$77,503,075	$50,466,079	$29,210,909	$28,777,244
Total Non Current Liabilities Net Minority Interest	$22,783,056	$26,403,264	$13,068,068	$12,109,087
Derivative Product Liabilities	$1,789,427	-	-	-
Non Current Deferred Liabilities	$761,149	$548,787	$10,059	$0
Non Current Deferred Taxes Liabilities	$0	$21,236	$10,059	$0
Current Liabilities	$54,720,019	$24,062,815	$16,142,841	$16,668,157
Other Current Liabilities	$1,686,599	$1,627,361	$324,131	$10,059
Current Deferred Liabilities	$999,218	$130,770	$0	-
Payables And Accrued Expenses	$24,850,788	$19,768,638	$13,576,618	$14,735,666
Payables	$10,453,784	$9,015,313	$6,806,751	$6,323,908
Total Tax Payable	$4,677,546	$4,825,081	$2,221,974	$4,084,051
Accounts Payable	$5,776,238	$4,190,231	$4,584,777	$2,093,439
Other Non Current Liabilities	-	$944,451	-	$1,118
Other Payable	-	-	$223,539	$146,418
Equity
Common Stock Equity	$54,911,144	$126,583,214	$109,558,513	$134,485,305
Total Equity Gross Minority Interest	$54,911,144	$126,583,214	$109,558,513	$134,485,305
Stockholders Equity	$54,911,144	$126,583,214	$109,558,513	$134,485,305
Other Equity Interest	$13,853,806	$10,394,546	$8,562,647	$6,309,378
Gains Losses Not Affecting Retained Earnings	$1,256,287	$1,021,571	$153,124	$196,714
Other Equity Adjustments	$1,256,287	$1,021,571	$153,124	$196,714
Retained Earnings	$-342,046,502	$-243,360,907	$-179,757,464	$-132,124,737
Other
Ordinary Shares Number	$48,090,377	$41,832,196	$32,048,715	$28,888,208
Share Issued	$48,090,377	$41,832,196	$32,048,715	$28,888,208
Tangible Book Value	$-1,094,222	$70,272,718	$57,465,073	$89,808,876
Invested Capital	$98,567,119	$147,789,206	$119,323,798	$144,072,876
Working Capital	$13,697,329	$85,563,878	$60,252,600	$95,391,753
Capital Lease Obligations	$1,582,653	$4,113,111	$4,433,889	$3,693,976
Total Capitalization	$72,871,355	$147,512,018	$118,916,957	$143,638,093
Additional Paid In Capital	$374,576,959	$351,341,238	$275,094,450	$255,141,392
Capital Stock	$7,270,594	$7,186,767	$5,505,756	$4,962,557
Common Stock	$7,270,594	$7,186,767	$5,505,756	$4,962,557
Non Current Deferred Revenue	$761,149	$527,551	$0	-
Long Term Capital Lease Obligation	$711,971	$2,863,530	$3,482,732	$2,890,354
Long Term Provisions	$1,560,300	$1,117,693	$206,773	$65,944
Current Deferred Revenue	$999,218	$130,770	$0	-
Current Capital Lease Obligation	$870,683	$1,249,581	$951,157	$803,621
Pensionand Other Post Retirement Benefit Plans Current	$616,967	$1,009,277	$884,095	$684,028
Current Accrued Expenses	$14,397,005	$10,753,325	$6,769,867	$8,411,758
Net PPE	$5,974,070	$9,219,850	$8,914,720	$6,280,318
Accumulated Depreciation	$-5,522,522	$-6,358,556	$-4,541,187	$-3,091,539
Gross PPE	$11,496,591	$15,578,406	$13,455,907	$9,371,857
Leases	$4,600,425	$2,052,085	$1,468,649	$786,856
Construction In Progress	$33,531	$2,524,869	$2,296,859	$802,504
Other Properties	$1,993,964	$2,125,852	$1,677,657	$1,397,116
Machinery Furniture Equipment	$2,968,593	$3,222,309	$2,866,883	$2,334,861
Buildings And Improvements	$1,900,078	$5,653,292	$5,145,859	$4,050,520
Properties	$0	$0	$0	$0
Finished Goods	$1,669,833	$1,218,285	$509,668	$317,425
Work In Process	$2,068,850	$2,845,647	$1,710,070	$111,769
Raw Materials	$1,469,766	$1,207,109	$1,485,414	$556,611
Other Short Term Investments	$20,118,476	$57,414,777	$40,391,193	$86,026,603
Employee Benefits	-	$0	$10,059	$0
Non Current Pension And Other Postretirement Benefit Plans	-	$0	$10,059	$0
Preferred Stock	-	-	-	$0

Fetched: 2026-10-26

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-81,309,938	$-61,806,193	$-62,300,213	$-50,413,547
Operating Activities
Operating Cash Flow	$-77,097,352	$-55,019,561	$-50,048,062	$-32,140,383
Cash Flow From Continuing Operating Activities	$-77,097,352	$-55,019,561	$-50,048,062	$-32,140,383
Operating Gains Losses	$1,715,659	$-1,987,258	$1,033,866	$-3,223,427
Investing Activities
Capital Expenditure	$-4,212,585	$-6,786,633	$-12,252,152	$-18,273,164
Investing Cash Flow	$31,666,481	$-18,246,340	$35,778,474	$-100,532,024
Cash Flow From Continuing Investing Activities	$31,666,481	$-18,246,340	$35,778,474	$-100,532,024
Capital Expenditure Reported	$-3,312,842	$-5,484,520	$-9,457,919	$-17,282,888
Financing Activities
Issuance Of Capital Stock	$23,319,549	$77,927,798	$20,495,138	$285,012
Financing Cash Flow	$42,591,931	$86,553,036	$18,842,070	$-1,098,692
Cash Flow From Continuing Financing Activities	$42,591,931	$86,553,036	$18,842,070	$-1,098,692
Net Other Financing Charges	$-3,633,620	$-292,836	$-57,002	$-41,355
Cash Dividends Paid	$0	$0	$0	$0
Net Common Stock Issuance	$23,319,549	$77,927,798	$20,495,138	$285,012
Common Stock Issuance	$23,319,549	$77,927,798	$20,495,138	$285,012
Other
Repayment Of Debt	$-1,466,413	$-1,704,482	$-1,381,469	$-1,197,049
Issuance Of Debt	$25,148,095	$11,176,931	$0	$0
End Cash Position	$33,531,911	$38,209,456	$24,153,348	$19,993,294
Beginning Cash Position	$38,209,456	$24,153,348	$19,993,294	$151,457,474
Effect Of Exchange Rate Changes	$-1,838,605	$768,973	$-412,429	$2,306,919
Changes In Cash	$-2,838,940	$13,287,136	$4,572,482	$-133,771,099
Interest Paid Cff	$-775,679	$-554,376	$-214,597	$-145,300
Net Issuance Payments Of Debt	$23,681,681	$9,472,449	$-1,381,469	$-1,197,049
Net Long Term Debt Issuance	$23,681,681	$9,472,449	$-1,381,469	$-1,197,049
Long Term Debt Payments	$-1,466,413	$-1,704,482	$-1,381,469	$-1,197,049
Long Term Debt Issuance	$25,148,095	$11,176,931	$0	$0
Interest Received Cfi	$2,405,276	$2,524,869	$2,581,871	$122,946
Net Investment Purchase And Sale	$33,470,438	$-13,992,400	$45,448,755	$-82,381,805
Sale Of Investment	$80,469,432	$95,352,634	$134,884,321	$32,315,861
Purchase Of Investment	$-46,998,995	$-109,345,034	$-89,435,566	$-114,697,666
Net PPE Purchase And Sale	$-896,390	$-1,294,289	$-2,794,233	$-990,276
Sale Of PPE	$3,353	$7,824	$0	$0
Purchase Of PPE	$-899,743	$-1,302,112	$-2,794,233	$-990,276
Taxes Refund Paid	$-1,165,754	$-597,966	$-881,860	$-458,254
Change In Working Capital	$6,003,130	$3,310,607	$-3,905,220	$96,122
Change In Payables And Accrued Expense	$8,332,402	$5,715,883	$535,375	$687,381
Change In Payable	$8,332,402	$5,715,883	$535,375	$687,381
Change In Inventory	$62,591	$-1,565,888	$-2,719,347	$-599,084
Change In Receivables	$-2,391,863	$-839,388	$-1,721,247	$7,824
Other Non Cash Items	$3,080,362	$-1,057,338	$-2,179,502	$-181,066
Stock Based Compensation	$5,461,048	$4,435,006	$2,918,297	$3,015,536
Unrealized Gain Loss On Investment Securities	$57,002	$0	$0	-
Provisionand Write Offof Assets	$421,370	$913,155	$241,422	$41,355
Asset Impairment Charge	$1,877,724	$0	$0	-
Depreciation Amortization Depletion	$5,011,736	$3,037,890	$2,637,756	$2,159,383
Depreciation And Amortization	$5,011,736	$3,037,890	$2,637,756	$2,159,383
Amortization Cash Flow	$2,492,456	$1,079,692	$1,075,221	$908,684
Amortization Of Intangibles	$2,492,456	$1,079,692	$1,075,221	$908,684
Depreciation	$2,519,280	$1,958,198	$1,562,535	$1,250,699
Gain Loss On Investment Securities	$-1,772,661	$450,430	$-282,776	$3,040,125
Net Foreign Currency Exchange Gain Loss	$3,307,254	$-2,437,689	$1,316,642	$-6,263,552
Gain Loss On Sale Of PPE	$181,066	$0	$0	-
Net Income From Continuing Operations	$-99,559,631	$-63,073,657	$-49,912,821	$-33,593,384
Interest Received Cfo	-	$0	$0	$3,353

Fetched: 2026-10-26